paclitaxel has been researched along with Scleroderma, Localized in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chanloung, W; Kasitanon, N; Ketpueak, T; Louthrenoo, W; Nan, KN; Pongsananurak, C | 1 |
| De Haes, P; Morren, MA; Noë, E; Van Cutsem, E; Van den Oord, JJ; Verhulst, L; Verslype, C | 1 |
| Fernández, M; Garcías, J; Pérez, A; Torregrosa, JL | 1 |
| Ashida, A; Koga, H; Minagawa, A; Ohashi, A; Okuyama, R; Uhara, H | 1 |
| Jensen, S; Krarup-Hansen, A; Pedersen, JV; Riis, L | 1 |
| Fujimoto, T; Fukuda, J; Konishi, Y; Sato, H; Sato, N; Tanaka, T | 1 |
| Balguerie, X; Chinet, P; Courville, P; Joly, P; Kupfer, I | 1 |
| Battafarano, DF; Burris, HA; Keeling, JH; Older, SA; Zimmerman, GC | 1 |
2 review(s) available for paclitaxel and Scleroderma, Localized
| Article | Year |
|---|---|
Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.
Topics: Acute Kidney Injury; Erythema; Female; Humans; Male; Paclitaxel; Scleroderma, Diffuse; Scleroderma, Localized; Scleroderma, Systemic; Taxoids | 2022 |
Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Eruptions; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Scleroderma, Localized | 2018 |
6 other study(ies) available for paclitaxel and Scleroderma, Localized
| Article | Year |
|---|---|
[Morphea type plaques induced by paclitaxel].
Topics: Antineoplastic Agents, Phytogenic; Female; Humans; Middle Aged; Paclitaxel; Scleroderma, Localized | 2014 |
Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; Humans; Middle Aged; Paclitaxel; Prednisolone; PUVA Therapy; Scleroderma, Localized | 2015 |
Scleroderma induced by paclitaxel.
Topics: Antineoplastic Agents, Phytogenic; Female; Genetic Predisposition to Disease; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Peritoneal Neoplasms; Scleroderma, Localized; Sex Factors; Time Factors | 2010 |
Scleroderma-like cutaneous lesions induced by paclitaxel and carboplatin for ovarian carcinoma, not a single course of carboplatin, but re-induced and worsened by previously administrated paclitaxel.
Topics: Aged; Carboplatin; Carcinoma; Female; Humans; Ovarian Neoplasms; Paclitaxel; Scleroderma, Localized | 2010 |
Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
Topics: Antineoplastic Agents, Phytogenic; Drug Eruptions; Erythema; Fatal Outcome; Female; Humans; Middle Aged; Paclitaxel; Scleroderma, Localized | 2003 |
Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases.
Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Docetaxel; Edema; Female; Humans; Leg; Leiomyosarcoma; Lung Neoplasms; Male; Melanoma; Middle Aged; Paclitaxel; Scleroderma, Localized; Taxoids | 1995 |